When samples of bacterial infections are sent to pathology labs for testing, the results are usually reported in one of two ways: The bacterium is susceptible to treatment with major antibiotics or it’s resistant. But there’s a third type of infection that infectious disease clinicians are increasingly seeing as worthy of recognition—heteroresistant. Heightened awareness of this phenomenon could improve prognoses for patients with tough-to-beat
JULY 15, 2020